Sabin Begins Marburg Vaccine Clinical Trial in U.S.

Sabin Begins Marburg Vaccine Clinical Trial in U.S.

Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S.

Format

JPEG

Source

Sabin Vaccine Institute

Téléchargements